US Stock MarketDetailed Quotes

VSTM Verastem

Watchlist
  • 5.9200
  • +0.3300+5.90%
Close Jan 24 16:00 ET
  • 5.9500
  • +0.0300+0.51%
Post 20:01 ET
263.48MMarket Cap-1.89P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Jan 23 06:31
    NEWS
    $Verastem (VSTM.US)$
    Verastem Oncology Outlines 2025 Strategic Priorities and Milestones for Novel Pipeline Targeting RAS/MAPK Pathway-Driven Cancers
    Thursday, 23rd January at 7:30 am
    Avutometinib plus defactinib granted priority review by FDA, under the accelerated approval pathway, for recurrent KRAS mutant LGSOC; PDUFA action date set for June 30, 2025
    Potential U.S. commercial launch in recurrent KRAS mutant LGSOC planned for mid-2025
    RAMP 205 trial in 1L metastatic pancreatic cancer cont...
    Jaguar8
    Jaguar8
    Jan 14 06:31
    NEWS
    $Verastem (VSTM.US)$
    Verastem Oncology Exercises Option Early to License VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, from GenFleet Therapeutics and Provides Preliminary Clinical Update on Phase 1 Study in China
    Tuesday, 14th January at 7:30 am
    VS-7375 is a potential best-in-class oral and selective KRAS G12D (ON/OFF) inhibitor currently in Phase 1 development in China in advanced KRAS G12D mutant solid tumors; Verastem anticipates filing a U.S. IND application for VS-7375 during Q1 2025​ a...
    Jaguar8
    Jaguar8
    Jan 13 06:32
    NEWS
    $Verastem (VSTM.US)$
    Verastem Oncology Announces Debt Refinancing with Oberland Capital and Strategic Commercialization Partnership with IQVIA to Support Potential Launch in Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer in Mid-2025
    Monday, 13th January at 7:30 am
    Company cash, cash equivalents, and investments of $88.8 million as of December 31, 2024; pro forma cash position of $128.6 million including debt refinancing and equity issuance provides cash runway beyond FDA approval
    Veras...
    joeyboulevard
    joeyboulevard
    Jan 2 10:10
    $Verastem (VSTM.US)$ where is this 6.28 resistance you speak of?
    1
Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
GVS
870976
+29.98%
Hangzhou CNCR-IT
300250
+20.03%
Shanghai Newtouch Software
688590
+20.01%
4
Ucap Cloud Information Technology Co.,Ltd
688228
+20.00%
5
Yangtze Optical Electronic
688143
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks Show More
Ask a strategist - Trump's first day
China Concept Stocks
Tracking the US-listed Chinese companies.